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Neurotropic viruses, including mammalian reovirus,
must disseminate from an initial site of replication to
the central nervous system (CNS), often binding mul-
tiple receptors to facilitate systemic spread. Reovirus
engages junctional adhesion molecule A (JAM-A) to
disseminate hematogenously. However, JAM-A is
dispensable for reovirus replication in the CNS. We
demonstrate that reovirus binds Nogo receptor
NgR1, a leucine-rich repeat protein expressed in the
CNS, to infect neurons. Expression of NgR1 confers
reovirus binding and infection of nonsusceptible
cells. Incubating reovirus virions with soluble NgR1
neutralizes infectivity. Blocking NgR1 on transfected
cells or primary cortical neurons abrogates reovirus
infection. Concordantly, reovirus infection is ablated
in primary cortical neurons derived from NgR1 null
mice. Reovirus virions bind to soluble JAM-A and
NgR1, while infectious disassembly intermediates
(ISVPs) bind only to JAM-A. These results suggest
that reovirus uses different capsid components to
bind distinct cell-surface molecules, engaging inde-
pendent receptors to facilitate spread and tropism.
INTRODUCTION
Engagement of cellular receptors by viruses is a major determi-
nant of pathogenesis, often dictating host range, mediating
spread, and influencing virulence. Neurotropic viruses must
navigate diverse cellular and tissue environments to disseminate
from an initial site of replication in the periphery to tissues within
the CNS, often guided by different receptors along the way
(Schneider-Schaulies, 2000; Schweighardt and Atwood, 2001).
Spread may occur hematogenously, providing direct entry to
the CNS through vascular endothelium, or along nerves. Expres-
sion and engagement of specific cell-surface molecules likely
dictates these distinct pathways of viral spread and tropism.
Mammalian reoviruses are nonenveloped, double-stranded
RNA viruses that use both hematogenous and neural pathwaysCell Hto spread from an initial site of replication in the intestine to the
CNS (Boehme et al., 2013b). Most mammals, including humans,
are hosts for reovirus infection. While infection seldom results in
human disease, rare cases of reovirus encephalitis in young
children have beendocumented (Ouattara et al., 2011). Following
peroral inoculationof newbornmice, reovirus is takenupby intes-
tinal M cells and undergoes primary replication in gut-associated
lymphoid tissue before accessing a variety of organs including
the heart, liver, and brain (Morrison et al., 1991; Virgin et al.,
1997). Reovirus displays exquisite serotype-specific patterns of
dissemination, tropism within the CNS, and disease outcome.
Type1 (T1) reoviruses spreadhematogenously, infect ependymal
cells, and cause hydrocephalus, whereas type 3 (T3) reoviruses
spread by both hematogenous and neural routes, infect neurons,
and cause lethal encephalitis (Antar et al., 2009; Tyler et al., 1986;
Weiner et al., 1980). Viral replication and neural pathology coloc-
alize, with a strong predilection for the cerebral cortex, hippo-
campus, and thalamus (Antar et al., 2009; Oberhaus et al.,
1997). Cellular factors that regulate these patterns of systemic
dissemination and tropism are unknown. However, the viral s1
attachment protein is a primary determinant of spread to the
CNS (Tyler et al., 1986; Weiner et al., 1980), indicating a key
role for receptor recognition in dictating the outcome of infection.
Reovirus initially tethers to the cell surface by s1 engagement
of sialylated glycans with low affinity (Barton et al., 2001a;
Chappell et al., 2000; Reiss et al., 2012), which is followed by
higher affinity binding to proteinaceous receptors via an adhe-
sion-strengthening mechanism (Barton et al., 2001a). JAM-A,
an immunoglobulin superfamily protein expressed in tight junc-
tions and on hematopoietic cells, is the only known proteina-
ceous receptor for reovirus (Barton et al., 2001b; Campbell
et al., 2005). Engagement of endothelial JAM-A is required for
establishment of viremia and bloodstream dissemination from
the intestine to sites of secondary replication in the host (Antar
et al., 2009). However, JAM-A is not required for the distinct
patterns of reovirus tropism or replication in the CNS. Moreover,
reovirus replicates and causes neurologic disease in JAM-A-
deficient (JAM-A/) mice following intracranial inoculation
(Antar et al., 2009), indicating the existence of alternative neural
receptors for reovirus. However, the identity of such receptors is
unknown.
We used a whole-genome siRNA screen to identify Nogo
receptor NgR1 as a reovirus entry mediator. NgR1 is aost & Microbe 15, 681–691, June 11, 2014 ª2014 Elsevier Inc. 681
Figure 1. Expression of NgR1 Confers
Reovirus Infection of Nonsusceptible Cells
CHO cells were either mock transfected or tran-
siently transfected with plasmid encoding NgR1,
JAM-A, or CAR. After 48 hr, cells were pretreated
with PBS, a CAR-specific antibody, or with in-
creasing concentrations of NgR1-specific anti-
body prior to being adsorbed with reovirus
T3SA at anmoi of 10 PFU/cell. Cells were fixed at
20 hr and scored for reovirus antigen (green) using
indirect immunofluorescence.
(A) Representative images are shown.
(B) Results are expressed as the mean FFU/field
for three fields of view in triplicate samples. Error
bars indicate SD. **p < 0.005; ***p < 0.0005 (as
determined by Student’s t test in comparison to
NgR1-transfected cells). See also Figures S2, S3,
and S6.
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NgR1 Mediates Reovirus Neural Infectionglycosylphosphatidylinositol (GPI)-anchored, leucine-rich repeat
(LRR) protein expressed on the surface of neurons (Barton et al.,
2003; Fournier et al., 2001; He et al., 2003; Wang et al., 2002b).
When ligated by one of several myelin-associated proteins,
NgR1 elicits intracellular signaling via coreceptors to regulate
axonal plasticity in the developing brain and inhibit axonal
outgrowth in the adult CNS (Akbik et al., 2012; Hunt et al.,
2002; McGee and Strittmatter, 2003). Blockade of NgR1 or its
myelin-derived ligands promotes axonal regeneration (Fournier
et al., 2002; GrandPre´ et al., 2002; Li et al., 2004; Wang et al.,
2011). As such, the NgR1 pathway has been targeted pharmaco-
logically to improve recovery following stroke and other forms of
CNS injury (Lee and Zheng, 2012).
We demonstrate here that NgR1 serves as a reovirus receptor.
Expression of NgR1 permits reovirus binding and infection of
otherwise nonsusceptible cells. Blocking cell-surface NgR1
abrogates infection, including that of primary cortical neurons,
a main target of reovirus infection in vivo. Importantly, reovirus
infection is ablated in cortical neurons derived from NgR1 null
(NgR1/) mice. Reovirus virions bind directly to soluble
JAM-A and NgR1. However, distinct capsid components
mediate these interactions. These results indicate that NgR1
functions as a neural receptor for reovirus, providing evidence
that multiple receptors are used to facilitate reovirus systemic
spread and CNS tropism.
RESULTS
Expression of NgR1 Confers Reovirus Infection of
Nonsusceptible Cells
Binding to JAM-A is required for reovirus bloodstream dissemi-
nation (Antar et al., 2009). However, JAM-A is not required for
the distinct patterns of reovirus tropism in the brain, nor does it682 Cell Host & Microbe 15, 681–691, June 11, 2014 ª2014 Elsevier Inc.serve as a reovirus receptor on cultures
of primary cortical neurons (see Figure S1
available online). These data indicate that
alternate receptors for reovirus are ex-
pressed on neurons. To identify host mol-
ecules required for reovirus-induced cell
toxicity, including new receptor candi-dates, we performed a genome-wide siRNA screen using HeLa
cells. NgR1 was identified as a top cellular target that when in-
hibited by siRNA knockdown, protected T3 reovirus-infected
cells from death (Figure S2). Likewise, JAM-A was identified in
the screen, suggesting that in some contexts both NgR1 and
JAM-A are required for productive infection (B.A.M. and
T.S.D., unpublished data). While NgR1 is expressed on cervical
epithelial cells, which are the origin of HeLa cells, NgR1 expres-
sion is most prominent on the surface of CNS neurons (Wang
et al., 2002b), including neural cell populations that are targeted
by T3 reovirus in vivo (Antar et al., 2009; Oberhaus et al., 1997).
Therefore, we investigated NgR1 as a putative reovirus receptor.
To test the hypothesis that NgR1 functions as a reovirus
receptor, we determined whether expression of NgR1 allows
infection of Chinese hamster ovary (CHO) cells, which are not
susceptible to reovirus. CHO cells were transfected with plas-
mids encoding NgR1, JAM-A as a positive control, or the
coxsackievirus and adenovirus receptor (CAR) as a negative
control, and infected with strain T3SA, which is neurotropic
but incapable of binding sialic acid (SA) (Antar et al., 2009; Barton
et al., 2001a). The use of T3SA allows the role of NgR1 engage-
ment to be isolated from that of SA in reovirus infectivity. As
expected, JAM-A expression allowed reovirus infection of
CHO cells, while CAR-transfected cells remained refractory
(Figure 1). Expression of NgR1 also permitted reovirus infection
of CHO cells, with a greater than 100-fold increase in the number
of infected cells over that in mock- or CAR-transfected cells.
Incubation of cells with NgR1-specific antibodies prior to infec-
tion abrogated NgR1-mediated infectivity in a dose-dependent
manner, suggesting that NgR1 acts to promote reovirus infection
at the viral attachment step (Figure 1). In contrast, treatment of
transfected cells with neuraminidase (NA) had no effect on
NgR1-mediated infectivity, indicating that sialylated glycans
Figure 2. Expression of NgR1 Allows
Reovirus Binding to Nonsusceptible Cells
CHO cells were either mock transfected or tran-
siently transfected with plasmid encoding NgR1 or
JAM-A. After 48 hr, cells were treated with PBS or
antibodies specific for JAM-A or NgR1 prior to
being incubated with 105 particles/cell of Alexa
Fluor 546-labeled reovirus T3SA on ice for 1 hr.
The percentage of cells bound by virus was
quantified by flow cytometry.
(A) Representative flow cytometric profiles are
shown.
(B) Results are expressed as the percent cells
bound by virus for triplicate samples. Error bars
indicate SD. **p < 0.005; ***p < 0.0005 (as
determined by Student’s t test in comparison to
NgR1- or JAM-A-transfected cells).
Cell Host & Microbe
NgR1 Mediates Reovirus Neural Infectionare not required for the observed infectivity enhancement (Fig-
ure S3). Thus, expression of NgR1 permits reovirus infection of
normally nonsusceptible cells.
Expression of NgR1 Allows Reovirus Binding to
Nonsusceptible Cells
To determine whether NgR1 facilitates infection by enhancing
viral attachment, we assessed the capacity of NgR1 expression
to increase reovirus binding to the cell surface. CHO cells were
mock transfected or transfected with plasmids encoding NgR1
or JAM-A, incubated with fluoresceinated reovirus T3SA, and
scored for reovirus binding using flow cytometry (Figure 2). Both
JAM-A and NgR1 significantly increased the capacity of
reovirus to bind CHO cells, with 85%–90% of cells having
bound viral particles compared with 29% of mock-transfected
cells (Figures 2A and 2B). When cells were treated with anti-
bodies directed against each receptor prior to infection,
reovirus binding was inhibited in an antibody-specific and
dose-dependent manner (Figure 2B). These data suggest that
NgR1 confers reovirus infectivity by allowing virus binding to
the cell surface.
Reovirus Infectivity Is Abrogated when NgR1 Is
Removed from the Cell Surface
Phosphatidylinositol-specific phospholipase C (PI-PLC) cleaves
phosphatidylinositol and serves as an efficient means to
release most GPI-anchored proteins from the cell surface,
including NgR1 (Fournier et al., 2001). As an additional
approach to test whether surface-expressed NgR1 mediates
reovirus infection, we used PI-PLC to remove the molecule
from the cell surface prior to reovirus adsorption. CHO cells
were mock transfected or transfected with plasmids encoding
NgR1 or JAM-A, incubated with increasing concentrations of
PI-PLC for 1 hr prior to inoculation with reovirus T3SA, and
scored for reovirus antigen. Cleaved soluble NgR1 was de-
tected in culture supernatants following PI-PLC treatment
(Figure S4). NgR1 expression permitted reovirus infection of
otherwise nonsusceptible CHO cells, as did JAM-A as a posi-
tive control (Figure 3A). PI-PLC treatment significantly dimin-
ished NgR1-mediated reovirus infectivity (Figure 3A), whereas
PI-PLC treatment had no effect on infectivity mediated by
JAM-A.Cell HTreatment of Virions with Soluble NgR1 Neutralizes
Reovirus Infectivity
If reovirus can bind cell-surface NgR1 to infect cells, incubation
of virions with soluble NgR1 protein should neutralize NgR1-
mediated infectivity. To test this hypothesis, we incubated
T3SA virions with soluble Fc-tagged versions of NgR1,
JAM-A, or CAR prior to inoculation of CHO cells transfected
with these receptor molecules. Virus treated with PBS or
soluble CAR remained infectious and efficiently replicated in
CHO cells expressing JAM-A or NgR1 (Figure 3B). As expected,
treatment of virions with soluble JAM-A neutralized infection of
JAM-A-expressing cells. Likewise, treatment of virions with
soluble NgR1 effectively abolished infectivity of NgR1-express-
ing cells, suggesting that virions and soluble NgR1 interact
to prevent the virus from binding cell-associated NgR1.
Interestingly, while treatment of virions with soluble JAM-A
cross-neutralized infection of NgR1-expressing cells, virions
pretreated with soluble NgR1 remained capable of infecting
JAM-A-expressing cells (Figure 3B). These results suggest
that NgR1 and JAM-A bind distinct components of reovirus
virions to mediate infection.
Blocking Access to Cell-Surface NgR1 Diminishes
Reovirus Infection of Neurons
To determine whether NgR1 serves as a reovirus receptor on
neurons, we established primary cultures of murine cortical neu-
rons, which are a primary target of T3 reovirus infection in vivo
(Antar et al., 2009). Cultured cortical neurons are susceptible to
T3 reovirus infection but not T1 reovirus, mimicking the patterns
of serotype-specific tropism observed in vivo (Antar et al., 2009;
Dichter and Weiner, 1984). While JAM-A does not serve as a
reovirus receptor on cortical neurons (Figure S1), NgR1 is ex-
pressed on murine cortical neurons both in culture (Figure S5)
and in vivo (Wang et al., 2002b). Cortical neurons prepared
from wild-type (Figure 4A) or JAM-A/ (Figure 4B) embryos
were pretreated with either PBS or antibodies specific for
JAM-A or NgR1 prior to inoculation with SA-binding reovirus
strain T3SA+. While engagement of SA is not required for infec-
tion of cortical neurons, reovirus strains that bind SA infect these
cells more efficiently than those that do not, allowing for a higher
baseline level of infectivity (Antar et al., 2009; Frierson et al.,
2012). Treatment of neurons with NgR1-specific antibodies priorost & Microbe 15, 681–691, June 11, 2014 ª2014 Elsevier Inc. 683
Figure 3. Reovirus Infectivity Is Abrogated when NgR1 Is Removed
from the Cell Surface or by Treatment of Virions with Soluble NgR1
Protein
CHO cells were eithermock transfected or transiently transfectedwith plasmid
encoding NgR1 or JAM-A for 48 hr.
(A) Transfected cells were treated with PI-PLC, which cleaves GPI-anchored
proteins, for 1 hr prior to adsorption with reovirus T3SA at an moi of 10 PFU/
cell.
(B) Reovirus T3SA was incubated with soluble Fc-tagged NgR1, JAM-A, or
CAR at the indicated concentrations prior to inoculation of transfected cells at
an moi of 10 PFU/cell. (A and B) Cells were fixed at 20 hr and scored for
reovirus antigen using indirect immunofluorescence. Results are expressed as
the mean FFU/field for three fields of view in triplicate samples. Error bars
indicate SD. **p < 0.005; ***p < 0.0005 (as determined by Student’s t test in
comparison to NgR1- or JAM-A-transfected cells). See also Figure S4.
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dose dependent, whereas JAM-A-specific antibodies had no
effect on infection (Figures 4A and 4B). These results suggest
that NgR1 facilitates reovirus infection of cortical neurons.
Concordantly, treatment of cortical neurons with PI-PLC dimin-
ished T3SA+ infectivity (Figure 4C), providing evidence that
GPI-anchored cell-surface molecules such as NgR1 facilitate
reovirus infection of neurons.
To determine whether binding to soluble NgR1 neutralizes
reovirus neural infection, we incubated T3SA+ with increasing
concentrations of NgR1 prior to inoculation of cortical neuron
cultures (Figures 4D and 4E). NgR1 treatment effectively abol-
ished T3SA+ infection of cortical neurons, with near-complete
neutralization at the highest concentration of NgR1 protein
tested (30 mg/ml). Importantly, incubation of T3SA+ with soluble
CAR had no effect on infection. However, soluble JAM-A was
capable of neutralizing T3SA+ neural infection (Figure 4D),684 Cell Host & Microbe 15, 681–691, June 11, 2014 ª2014 Elseviereven though JAM-A is not used as a receptor on these cells.
These results indicate that either soluble JAM-A or NgR1 can
neutralize the capacity of virions to infect NgR1-expressing
cells. However, the determinants of virus binding and mecha-
nisms of neutralization likely differ for the two receptor
molecules.
NgR1 Is Required for Efficient Reovirus Infection of
Cortical Neurons
To directly test whether NgR1 is required for reovirus infection of
neurons, we infected primary cortical neuron cultures prepared
from embryonic wild-type and NgR1/ mice (Kim et al., 2004)
with T3 reovirus. While reovirus T3SA+ and T3SA efficiently in-
fected wild-type neurons, infection ofNgR1/ neurons by these
strains was markedly diminished (Figures 5A and 5B). Residual
T3SA+ infectivity was further ablated following treatment of
NgR1/ neurons with NA prior to infection (Figure 5B). Addition-
ally, yields of reovirus T3SA+ and T3SA were significantly
diminished in NgR1/ neurons (Figure 5C). These results pro-
vide direct evidence that NgR1 is required for efficient infection
of cortical neurons, with glycan engagement enhancing NgR1-
mediated infectivity.
NgR1 Mediates Infection by Reovirus Virions but Not
ISVPs
Exposure of reovirus virions to proteases in the intestinal lumen
or in endocytic vesicles leads to formation of ISVPs (Ebert
et al., 2002; Johnson et al., 2009; Silverstein et al., 1972), which
are obligate intermediates in reovirus disassembly (Sturzen-
becker et al., 1987). ISVPs are characterized by loss of outer-
capsid protein s3, an extended conformer of s1, and cleavage
of outer-capsid protein m1 to form particle-associated frag-
ments d and F (Figure 6A). While ISVPs can bind sialylated gly-
cans and JAM-A to enter cells (Barton et al., 2001b), they do
not require endocytic proteolysis to initiate infection. To deter-
mine whether cell-surface NgR1 can mediate infection by
ISVPs, we transfected CHO cells with NgR1 or JAM-A and
compared infectivity using equal particle numbers of T3SA
virions or ISVPs. Both JAM-A and NgR1 allowed infection by
reovirus virions (Figure 6B). However, ISVPs failed to infect
NgR1-expressing cells in contrast to JAM-A-expressing cells
(Figure 6B). These findings indicate that reovirus uses different
viral components to engage JAM-A and NgR1. Furthermore,
our data suggest that reovirus engages NgR1 using either a
virion-associated conformer of s1 or outer-capsid protein s3.
Since s3 occludes m1 on virions, it is unlikely that m1 contrib-
utes to NgR1 binding.
Reovirus Virions, but Not ISVPs, Bind to Soluble NgR1
To determine whether reovirus particles bind directly to
NgR1, we used soluble Fc-tagged receptor proteins to assess
viral binding in independent assays. Fc-tagged versions of
NgR1, JAM-A, or CAR were immobilized onto protein G beads
and incubated with 1011 particles of either reovirus T3SA+
virions (Figure 7A) or ISVPs (Figure 7B) in a receptor-binding-
bead pull-down assay. Beads were washed extensively and
resuspended in protein-dissociation buffer. Precipitated mate-
rial was resolved by SDS-polyacrylamide gel electrophoresis
and visualized by colloidal blue staining. The intensity of bandsInc.
Figure 4. Blocking Access to Cell-Surface
NgR1 Diminishes Reovirus Infection of
Neurons
(A and B) Primary murine cortical neuron cultures
prepared from (A) wild-type JAM-A+/+ or (B)
isogenic JAM-A/ embryos were pretreated with
either PBS or antibodies specific for JAM-A or
NgR1 prior to adsorption with reovirus T3SA+ at
an moi of 500 PFU/cell.
(C) Neuron cultures prepared from wild-type
cortices were treated with PI-PLC at increasing
concentrations for 1 hr prior to adsorption with
reovirus T3SA+ at an moi of 500 PFU/cell.
(D) Reovirus T3SA+ was preincubated with
increasing amounts of soluble Fc-tagged NgR1,
JAM-A (30 mg/ml), or CAR (30 mg/ml) prior to
inoculation of wild-type neuron cultures at an moi
of 500 PFU/cell.
(A–D) Cells were fixed at 20 hr and scored for
reovirus antigen (green) using indirect immuno-
fluorescence. Results are expressed as the mean
FFU/field for three fields of view in triplicate
samples.
(E) Representative images of an experiment in (D)
are shown. Error bars indicate SD. *p < 0.05; **p <
0.005; ***p < 0.0005 (as determined by Student’s t
test in comparison to PBS-treated infected cells).
See also Figures S1 and S5.
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mined to quantify virus-receptor interactions. In contrast to
unconjugated control or CAR-conjugated beads, reovirus
virions were precipitated by JAM-A and NgR1 (Figures 7A
and 7C). Concordant with the infectivity data, reovirus ISVPs
were precipitated by JAM-A but not NgR1 (Figures 7B and
7C). These results indicate that reovirus virions bind directly
to NgR1.
In a complementary FLISA binding assay, ELISA plates were
coated with soluble Fc-tagged NgR1, JAM-A, or CAR and
adsorbed with serial dilutions of either T3SA+ virions (Figure 7D)
or ISVPs (Figure 7E). After extensive washing, plates were
incubated with reovirus-specific antibodies and fluorescent
secondary antibodies to detect virions or ISVPs bound to
immobilized receptor. Consistent with the bead-binding assay,
reovirus virions bound both JAM-A and NgR1, but ISVPs were
capable of binding only JAM-A. Together, our results demon-
strate that NgR1 directly interacts with virions, supporting the
hypothesis that NgR1 mediates reovirus infection at the cell
attachment step.Cell Host & Microbe 15, 681–6DISCUSSION
Reovirus spreads systemically by both
hematogenous and neural routes to
target specific cell populations in the
CNS. JAM-A, the only previously known
proteinaceous receptor for reovirus, is
required for bloodstream spread (Antar
et al., 2009). However, JAM-A is dispens-
able for reovirus neural dissemination and
tropism, indicating the existence of alter-
native receptors for reovirus in the ner-vous system. Results presented in this report demonstrate that
NgR1 serves as a neural entry mediator for reovirus, satisfying
criteria of a functional viral receptor. Expression of NgR1 by
otherwise nonsusceptible cells permits reovirus attachment
and infection. Antibodies specific for NgR1 effectively block
reovirus binding to and infectivity of NgR1-expressing cells,
including cultured primary cortical neurons. T3 reovirus fails to
infect cortical neurons derived from NgR1/ mice, providing
evidence that NgR1 is required for neural infection by reovirus. In-
cubation of virions with soluble NgR1 neutralizes reovirus infec-
tion of susceptible cells, suggesting specific binding of virions
by the receptor molecule. Finally and importantly, soluble NgR1
engages reovirus virions using two independent binding assays,
supporting a direct interaction between reovirus and NgR1.
NgR1 is a GPI-anchored neural receptor belonging to the LRR
family of proteins. Expressed on axons of maturing and adult
neurons, NgR1 engages ligands associated with myelin on the
surface of oligodendrocytes. NgR1 ligands are structurally
diverse and include members of the reticulin (Nogo-A) (Fournier
et al., 2001), immunoglobulin (myelin-associated glycoprotein)91, June 11, 2014 ª2014 Elsevier Inc. 685
Figure 5. NgR1 Is Required for Efficient
Reovirus Infection of Primary Cortical
Neurons
Primary murine cortical neuron cultures prepared
from wild-type NgR1+/+ or isogenic NgR1/ em-
bryos were pretreated with either PBS or NA prior
to adsorption with reovirus T3SA+ or T3SA at an
moi of 500 PFU/cell. Cells were fixed at 20 hr and
scored for reovirus antigen (green) using indirect
immunofluorescence.
(A) Representative images are shown.
(B) Results are expressed as the mean FFU/field
for three fields of view in triplicate samples.
(C) Primary murine cortical neuron cultures pre-
pared from wild-type NgR1+/+ or isogenic
NgR1/ embryos were adsorbed with reovirus
T3SA+ or T3SA at anmoi of 10 PFU/cell. Titers of
virus in cell lysates at the indicated intervals were
determined by plaque assay. Results are ex-
pressed as mean viral yields for triplicate samples.
Error bars indicate SD. **p < 0.005; ***p < 0.0005
(as determined by Student’s t test in comparison
to NgR1+/+ neurons). See also Figure S7.
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NgR1 Mediates Reovirus Neural Infection(Domeniconi et al., 2002; Liu et al., 2002), and LRR-containing
(oligodendrocyte myelin glycoprotein) (Wang et al., 2002a)
protein families. Eight central LRR domains flanked by LRR
N- and C-terminal subdomains are responsible for binding
ligands within the concave surface of NgR1 (Barton et al.,
2003; Laure´n et al., 2007). Following engagement of myelin-
associated proteins, NgR1 regulates neuronal remodeling in
the maturing brain, guiding axonal outgrowth during postnatal686 Cell Host & Microbe 15, 681–691, June 11, 2014 ª2014 Elsevier Inc.refinement of neural circuitry (Hu and
Strittmatter, 2004; Hunt et al., 2002).
Axonal expression of NgR1 increases
with age, as does myelination and the
corresponding expression of myelin-
associated ligands on oligodendrocytes
(Wang et al., 2002b). As such, high
concentrations of receptor and ligand
interact in the adult brain to effectively
restrict neural outgrowth and block
axonal repair.
T3 reovirus infects neurons and causes
encephalitis in newborn mice. However,
adult mice are protected from reovirus
CNS disease, becoming resistant to
infection within the first few weeks of
life. In the newborn CNS, NgR1 is
expressed at lower levels on neurons
(Wang et al., 2002b). However, the major-
ity of the newborn CNS is unmyelinated.
Therefore, the corresponding low con-
centrations of myelin-associated NgR1
ligands early in life may leave NgR1 free
to engage reovirus in the newborn CNS.
In fact, reovirus preferentially infects
unmyelinated nerve terminals in vivo
(Mann et al., 2002), where competition
for NgR1 by myelin-associated ligandswould presumably be absent. As the CNS matures and myelina-
tion becomes more evident, a richer environment of cellular
ligands may outcompete reovirus for binding to NgR1, possibly
explaining why myelinated neurons are not targeted for reovirus
invasion, and potentially providing a mechanism for the age
restriction of reovirus encephalitis (Tardieu et al., 1983).
If NgR1 serves as a reovirus receptor, expression of the mole-
cule should correspond to areas of reovirus tropism in the brain.
Figure 6. NgR1Mediates Infection of Reovirus Virions but Not ISVPs
(A) Reovirus virions undergo proteolytic disassembly leading to formation of
ISVPs. ISVPs are characterized by loss of outer-capsid protein s3, an
extended conformer of s1, and cleavage of outer-capsid protein m1 to form
d and F.
(B) CHO cells were transiently transfected with plasmids encoding NgR1 or
JAM-A and adsorbed with equal particle numbers of reovirus T3SA virions or
ISVPs. Cells were fixed at 20 hr scored for reovirus antigen using indirect
immunofluorescence. Results are expressed as the mean FFU/field for three
fields of view in triplicate samples. Error bars indicate SD. **p < 0.005; ***p <
0.0005 (as determined by Student’s t test in comparison to cells infected with
virions).
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T3 reovirus, including the thalamus, the middle and outer layers
of the cerebral cortex, the CA3 region of the hippocampus, and
cerebellar Purkinjie cells (Antar et al., 2009; Wang et al., 2002b).
Factors that facilitate the precise targeting of reovirus to these
specific brain regions are not understood. However, host recep-
tor expression is hypothesized as a probable mechanism
(Weiner et al., 1980). Importantly, JAM-A does not contribute
to reovirus neurotropism, as T3 reovirus infects similar regions
in the brain of wild-type and JAM-A/ mice (Antar et al.,
2009). The finding that NgR1 is required for infection of primary
cortical neurons suggests that NgR1 serves as a reovirus
receptor in at least a subset of CNS neurons.
Reovirus serotypes display striking differences in CNS
tropism, with T1 reovirus infecting ependymal cells causing
hydrocephalus and T3 reovirus infecting neurons causing
encephalitis. These differences are genetically linked to the s1
protein (Weiner et al., 1980), which supports the idea that recep-
tors for T1 reovirus are expressed on ependymal cells and those
for T3 reovirus are expressed on neurons. As is the case for
JAM-A (Barton et al., 2001b; Campbell et al., 2005), NgR1 is
capable of allowing infection by both T1 and T3 reovirus, at least
in transfected CHO cells (Figure S6). However, cultured primary
cortical neurons, which express NgR1, are susceptible only to T3
reovirus and remain refractory to T1 strains (Figure S7; AntarCell Het al., 2009; Dichter and Weiner, 1984). While NgR1 may be
capable of binding both serotypes when ectopically expressed
in cultured, nonneuronal cells, it is possible that an independent
cofactor is required for efficient T1 reovirus binding, entry, or
replication that is not expressed by neurons. Alternatively, addi-
tional receptors for reovirus may act in concert with NgR1 to
promote infection in the CNS. In this regard, it is possible that
differences in the cell-surface carbohydrates bound by T1 and
T3 reovirus, including the GM2 and GM3 gangliosides, respec-
tively, influence CNS tropism (Reiss et al., 2012). Glycan expres-
sion may route the virus to different regions of the brain, where
proteinaceous receptors are available for binding and entry
into neurons or ependymal cells. In support of this idea, glycan
binding enhances reovirus infection of neurons in culture
(Figure 5B) and permits efficient neural spread in vivo (Frierson
et al., 2012). Studies using NgR1/ mice, which are viable and
produce fertile offspring (Kim et al., 2004), will better define the
role of NgR1 in reovirus infection in vivo.
Experiments using reovirus virions and ISVPs demonstrate
that ISVPs are incapable of engaging NgR1, while both virions
and ISVPs efficiently bind JAM-A. Key structural differences
between these particle forms may offer insight into the identity
of the reovirus ligand for NgR1. During the transition from virions
to ISVPs, outer-capsid protein s3 is shed and s1 undergoes
conformational rearrangement from a more compact form found
on virions to an extended, flexible fiber on ISVPs (Dryden et al.,
1993; Furlong et al., 1988). Based on these observations, the
reovirus ligand for NgR1 is either s3 or the compact, virion-asso-
ciated conformer of s1 (Figure 7F). Cellular receptors have not
been reported for s3, as all available data for mammalian orthor-
eovirus are consistent with s1 serving as the viral attachment
protein. However, fiberless reovirus strains exist in nature. For
example, baboon reovirus (BRV) is a fusogenic reovirus that
lacks an adhesion fiber but does express sB, which is a s3
homolog (Yan et al., 2011). BRV causes meningoencephalomye-
litis in juvenile baboons, demonstrating that a fiber is not required
for reovirus neural spread or disease (Kumar et al., 2014; Leland
et al., 2000). While there are no reports of cellular receptors for
BRV, the NgR1-encoding gene is conserved in primates. Alter-
natively, conformational changes in s1 associated with the tran-
sition of virions to ISVPs have been hypothesized to alter the
capacity of s1 to interact with cell-surface receptors (Bokiej
et al., 2012; Dryden et al., 1993).
It is possible that different cellular environments encountered
by reovirus in vivo may influence what form of the virus is
exposed to host cells. ISVPs are formed by protease digestion
of virions in the intestinal lumen. Therefore, functional reovirus
receptors at that site should allow engagement by ISVPs. In
contrast, intact virions may be the infectious form of the virus
that disseminates via neural routes to deliver reovirus to the
brain. As such, the capacity of reovirus to use different viral
components to engage multiple, structurally distinct receptor
molecules may facilitate systemic spread in vivo.
Much remains to be learned about how NgR1 mediates
reovirus infection. It is possible that the kinetics of reovirus bind-
ing or entry differ depending on whether NgR1 or JAM-A is
engaged. Additionally, virus may be routed by these receptors
to different intracellular compartments. Of note, following bind-
ing to JAM-A, b1 integrin mediates internalization of reovirusost & Microbe 15, 681–691, June 11, 2014 ª2014 Elsevier Inc. 687
Figure 7. Reovirus Virions, but Not ISVPs,
Bind to Soluble NgR1
(A and B) Soluble Fc-tagged NgR1, JAM-A, or
CAR was immobilized onto protein G beads.
Receptor-conjugated beads were incubated with
1011 particles of either reovirus T3SA+ (A) virions
or (B) ISVPs, washed extensively, resuspended,
and boiled in protein-dissociation buffer to release
bound material. Precipitated proteins were
resolved by SDS-polyacrylamide gel electropho-
resis and visualized by colloidal blue staining.
(C) Reovirus l band intensity was quantified by the
Odyssey imaging system for three independent
experiments. Results are expressed as the mean
optical density relative to that of NgR1-precipated
l bands. Error bars indicate SD.
(D and E) Plates were coated with soluble Fc-
tagged NgR1, JAM-A, or CAR and adsorbed with
serial dilutions of reovirus T3SA+ virions (D) or
ISVPs (E) in a FLISA binding assay. Wells were
washed and incubated with reovirus-specific
antibodies and fluorescent secondary antibodies
to detect virions or ISVPs bound to receptor pro-
tein. Signal intensity was quantified using the
Odyssey imaging system. Results are shown as
the mean relative FLISA signal for three indepen-
dent experiments. Error bars indicate SD.
(F) Both reovirus virions and ISVPs efficiently bind
JAM-A. However, ISVPs are incapable of
engaging NgR1, suggesting that the reovirus
ligand for NgR1 is either s3 or the virion-associ-
ated conformer of s1.
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ators that facilitate reovirus entry following NgR1 engagement
are unknown. However, integrins are implicated in signaling
events following binding of cellular ligands to NgR1 (Hu and
Strittmatter, 2008). The NF-kB pathway is activated following
reovirus entry and serves a critical function in reovirus neuropa-
thology by precipitating apoptosis (O’Donnell et al., 2005). NgR1
lacks a transmembrane domain and instead relies on corecep-
tors to induce intracellular signaling, primarily through RhoA-
dependent pathways (Nikolic, 2002). Defining the downstream
signaling events that are initiated by reovirus binding to NgR1,
and the coreceptors responsible, may lead to a better
understanding of neural cell fate following reovirus infection.
The engagement of specific cellular receptors has major con-
sequences for viral tropism, pathogenesis, and virulence.
Viruses that spread systemically, like reovirus, may rely on the
coordinated engagement of distinct receptors to navigate
diverse host environments in vivo. Indeed, measles virus en-
gages specific receptors to facilitate spread from the periphery
to the CNS (Delpeut et al., 2012). By virtue of the multiple tissue688 Cell Host & Microbe 15, 681–691, June 11, 2014 ª2014 Elsevier Inc.types encountered in the infected host,
reovirus is an ideal system to investigate
stepwise mechanisms of spread and
tropism used by neurotropic viruses.
Identifying tissue-specific receptors for
reovirus, such as NgR1, will facilitate a
better understanding of reovirus patho-
genesis. Importantly, viral encephalitisremains a significant cause of morbidity and mortality worldwide
(Griffin, 2011). Knowledge of the cellular factors that mediate
viral neuroinvasion and neurotropism is paramount to devel-
oping strategies directed against agents of viral encephalitis.
Additionally, reovirus is currently being tested as an anticancer
therapeutic in phase I–III clinical trials (Maitra et al., 2012). New
information about cellular factors that influence reovirus infection
of specific host cells may enable improved oncolytic vector
design by facilitating more precise targeting of tumor cells. Our
data also highlight an additional role for NgR1 as a pathogen re-
ceptor. Since pathogen sensing is a well-known property of
other LRR proteins, including the Toll-like receptors and variable
lymphocyte receptors, it is possible that neural LRR proteins in
addition to NgR1 function as pathogen-recognition factors.EXPERIMENTAL PROCEDURES
Cells, Viruses, and Antibodies
CHO cells were grown in Ham’s F12 medium (GIBCO) supplemented to
contain 10% fetal bovine serum (Invitrogen), 100 U/ml penicillin, 100 mg/ml
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NgR1 Mediates Reovirus Neural Infectionstreptomycin, and 0.25 mg/ml amphotericin B. Primary murine cortical neu-
ronswere prepared frommurine brain tissue at embryonic day 15 as described
(Antar et al., 2009; Boehme et al., 2013a). L929 cells were maintained as
described (Barton et al., 2001a).
Reovirus strains T3SA and T3SA+ consist of nine gene segments from
reovirus T1L and the S1 gene segment from either non-SA-binding strain
T3C44 (T3SA) or SA-binding strain T3C44-MA (T3SA+) (Barton et al.,
2001a). Purified virions were prepared by cesium chloride gradient centrifuga-
tion from infected L929 cells (Furlong et al., 1988). Viral titers were determined
by plaque assay using L929 cells (Virgin et al., 1988). ISVPs were generated by
treating virions with a-chymotrypsin (Sigma) (Baer and Dermody, 1997).
Reovirus virions were labeled with succinimidyl ester Alexa Fluor 546 (A546;
Invitrogen) to generate fluoresceinated particles (Mainou and Dermody, 2012).
Purified immunoglobulin G (IgG) fractions of rabbit antisera raised against
reovirus (Barton et al., 2001a; Wetzel et al., 1997) were used to detect reovirus
antigen by indirect immunofluorescence, along with Alexa Fluor-conjugated
secondary antibodies (Invitrogen). JAM-A-specific monoclonal antibody
J10.4 (provided by Charles Parkos, Emory University) was used to block
human JAM-A on transfected cells. JAM-A-specific monoclonal antibody
BV20 (provided by Elisabetta Dejana, FIRC Institute of Molecular Oncology,
University of Milan) was used to block murine JAM-A on cortical neurons.
NgR1-specific polyclonal antibody AF1208 (R&D Systems) was used to block
NgR1 on CHO cells and cortical neurons. Antibodies against cell-surface pro-
teins were preincubated with cells at various concentrations in PBS at 37C for
1 hr prior to adsorption of virus.
Plasmids, Transient Transfection, and Quantitation of Reovirus
Infectivity
Plasmids encoding human JAM-A and human CAR have been described
(Barton et al., 2001b). Plasmid encoding human NgR1 was obtained from
OriGene Technologies. CHO cells were transfected with 0.5 mg of plasmid
using FuGENE 6 transfection reagent (Promega). After 48 hr, transfected cells
were adsorbed with reovirus virions or ISVPs at an moi of 10 PFU/cell. Cells
were fixed after 20 hr, and reovirus antigen was visualized by indirect immuno-
fluorescence (Barton et al., 2001a).
Assessment of Reovirus Binding by Flow Cytometry
Monolayers of transfected CHO cells were washed with PBS, detached with
Cellstripper (Cellgro), quenched with PBS containing 2% FBS, pelleted, and
incubated with 105 particles of A546-labeled reovirus T3SA in PBS on ice
for 1 hr (Mainou and Dermody, 2012). Cells were washed and fixed in PBS
containing 1% paraformaldehyde. For some experiments, anti-receptor anti-
bodies were incubated with detached cells at room temperature for 1 hr prior
to adsorption with virus. Cells were analyzed using an LSRII flow cytometer
(BD Bioscience) and quantified using FlowJo software.
Virus Replication
Primary cortical neuron cultures were adsorbed with reovirus at an moi of 10
PFU/cell for 1 hr, washed with PBS, and incubated for various intervals. Cells
were frozen and thawed twice prior to determination of viral titers by plaque
assay using L929 cells (Virgin et al., 1988). Viral yields were calculated accord-
ing to the following formula: log10 yieldtx = log10 (pfu/ml)tx  log10 (pfu/ml)t0,
where tx is the time postinfection.
PI-PLC Treatment
GPI-anchored proteins were removed from the cell surface by incubating cells
with various concentrations of PI-PLC (Molecular Probes) at 37C for 1 hr.
Cells were washed with serum-free media prior to adsorption with reovirus,
fixed at 20 hr, and scored for reovirus antigen.
Neutralization of Reovirus with Soluble Receptor Protein
Purification of soluble Fc-tagged human JAM-A and CAR proteins has been
described (Barton et al., 2001b). Fc-tagged humanNgR1 protein was obtained
from R&D Systems. Reovirus T3SA- was incubated with soluble Fc-tagged
NgR1, JAM-A, or CAR at various concentrations in PBS at 4C overnight.
Mock-treated virus was incubated in PBS at 4C overnight. Cells were inocu-
lated at an moi of 10 PFU/cell, fixed at 20 hr, and scored for reovirus antigen.Cell HNeuraminidase Treatment
Terminal SA residues were removed from cell-surface glycans by incubation
with 40 mU/mL A. ureafaciens NA at 37C for 1 hr. Cells were washed prior
to absorption with reovirus. After 20 hr incubation, cells were fixed and scored
for reovirus antigen.
Receptor-Binding Bead Pull-Down Assay
Soluble Fc-tagged NgR1, JAM-A, or CAR was immobilized onto protein G
beads (Dynabeads, Life Technologies) by incubating 25 mg protein per
100 ml beads in PBS at 4C for 4 hr. Receptor-conjugated beads were washed
with PBS and incubated with 1011 particles of reovirus T3SA+ virions or ISVPs
at 4C overnight. Beads were washed extensively, resuspended in protein-
dissociation buffer, and boiled to release boundmaterial. Precipitated proteins
were resolved by SDS-polyacrylamide gel electrophoresis and visualized by
colloidal blue staining (Invitrogen). Intensity of the reovirus l bands was quan-
tified using the Odyssey Imaging System (LI-COR Biosciences). Results are
expressed as the optical density relative to that of NgR1-precipated l bands.
Receptor-Binding Fluorescence-Linked Immunosorbent Assay
High-binding 96-well Immulon assay plates (Fisher Scientific) were coatedwith
20 mg/ml soluble Fc-tagged NgR1, JAM-A, or CAR in carbonate-bicarbonate
buffer at 4C overnight. Wells were incubated with LI-COR blocking buffer
(LI-COR Biosciences) at 4C for 4 hr and washed with PBS containing
0.05% Tween 20. Reovirus T3SA+ virions or ISVPs serially diluted in TBS con-
taining 0.1% BSA and 0.05% Tween were added to the wells and incubated at
4C overnight. Wells were washed prior to adding reovirus-specific mono-
clonal antibody 9BG5 (Burstin et al., 1982) at room temperature for 2 hr. Wells
were washed and incubated with fluorescent secondary antibodies (LI-COR)
at room temperature for 2 hr (Bokiej et al., 2012). Following washing, signal
intensity was quantified using the Odyssey Imaging System. Results are
expressed as the fluorescence-linked immunosorbent assay (FLISA) signal
relative to that of NgR1-coated wells.
Statistical Analysis
Means of results from triplicate samples were compared using an unpaired
Student’s t test. Statistical analyses were performed using Prism software
(GraphPad Software, Inc.). p values of <0.05 were considered to be statisti-
cally significant.
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